Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Brain Behav ; : e2789, 2022 Oct 28.
Article in English | MEDLINE | ID: covidwho-2094155

ABSTRACT

INTRODUCTION: This review highlights the potential mechanisms of neuromuscular manifestation of COVID-19, especially myasthenia gravis (MG). METHODS: An extensive literature search was conducted by two independent investigators using PubMed/MEDLINE and Google Scholar from its inception to December 2020. RESULTS: Exacerbations of clinical symptoms in patients of MG who were treated with some commonly used COVID-19 drugs has been reported, with updated recommendations of management of symptoms of neuromuscular disorders. Severe acute respiratory syndrome coronavirus 2 can induce the immune response to trigger autoimmune neurological disorders. CONCLUSIONS: Further clinical studies are warranted to indicate and rather confirm if MG in the setting of COVID-19 can pre-existent subclinically or develop as a new-onset disease.

2.
Cureus ; 13(10): e19106, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1555598

ABSTRACT

Background Vaccine hesitancy has been a huge challenge in controlling preventable diseases. With the emergence of coronavirus disease 2019 (COVID-19) vaccines, it is vital to know their acceptance rates among the masses. No comparative data is available on the current subject from Pakistan yet. Therefore, this study aimed to evaluate the acceptance of a potential COVID-19 vaccine among the general population and healthcare workers (HCWs) of Pakistan, along with their perceptions and barriers to acceptance. Methods An online cross-sectional study was carried out in Pakistan from December 19, 2020, to January 10, 2021, using convenience sampling. A self-administered questionnaire consisting of 31 items was distributed after informed consent. Inclusion criteria consisted of HCWs and non-HCWs (general population) aged 18 years and above, residing in Pakistan. All analyses were done using Statistical Package for Social Sciences (SPSS) version 23.0 (IBM Corp., Armonk, NY, USA). Chi-square and T-test were used and a p-value of less than 0.05 was considered significant for all cases. Results Of the 404 respondents (n=196 general population and n=208 HCWs), 73.5% were willing to get a proven, safe, and effective COVID-19 vaccine if it was free of cost. This was reduced to only 64.3% if the vaccine was not free and had to be paid for. A total of 168 (41.6%) participants agreed to get vaccinated immediately, while 149 (36.9%) participants concurred to get it on a delayed basis. Eighty-seven (21.5%) participants refused to receive the COVID-19 vaccine, amongst which a significant majority (p<0.001) of the participants were from the general population. Doctors or scientists/scholarly journals were found to be the most trusted source of information (67.6%; n=273), while fear of unknown side effects (45.5%; n=184) was found to be the most common barrier towards COVID-19 vaccination. More than half (53.5%) participants believed that the vaccine is safe, effective, and has minimal side effects, amongst which a significantly large fraction (p<0.001) belonged to the HCWs. Conclusion The acceptance rate of a safe, effective, proven, and free COVID-19 vaccine was 73.5%. The fear of unknown side effects was the most common barrier to COVID-19 vaccine uptake. The general population demonstrated less knowledge, more false perceptions, and barriers to COVID-19 vaccine. Adequate measures should be taken to educate the masses about the COVID-19 vaccine, and its safety, and further studies are required.

3.
J Nerv Ment Dis ; 209(9): 681-683, 2021 Sep 01.
Article in English | MEDLINE | ID: covidwho-1376357

ABSTRACT

ABSTRACT: The COVID-19 pandemic brought with itself significant mental health challenges owing not only to the morbidity and mortality from the infection but also to mitigation strategies of social distancing and self-isolation. Indeed, in the absence of adequate pharmaceutical aids, quarantine and social distancing measures are taken to limit the spread of the SARS-CoV-2 virus. Thus, living in the world of social media, the average usage of social media could be expected to show a sharp rise as measures of social distancing and quarantine are adopted to contain the pandemic. In this context, social media could be thought of as an additional preventative resource aiding the containment of the pandemic by being a key network for communication during a crisis.Because social media usage cannot be brought down to null considering the fact that it does have some positive aspects to it in terms of disposition of useful information, we could alternatively modify the reporting to be more responsible.In conclusion, we could hypothesize that social media might surge responses for some adverse mental health conditions, increasing fear, anxiety, and panic responses, even spreading suicidal ideation and therefore impacting incidence of suicide in some way. Moreover, social media should be carefully handled, particularly during the pandemic, as social media engagement spiked. Indeed, suicide news, when not reported adequately, and most dangerous social media challenges could have devastating effects among youngest users.


Subject(s)
COVID-19/psychology , Social Media/statistics & numerical data , Suicidal Ideation , Suicide Prevention , Humans , Mental Health/statistics & numerical data , Online Social Networking , Psychiatry/methods
4.
Acta Biomed ; 91(4): e2020161, 2020 11 10.
Article in English | MEDLINE | ID: covidwho-1058718

ABSTRACT

BACKGROUND: The spectrum of pre-existing renal disease is known as a risk factor for severe COVID-19 outcomes. However, little is known about the impact of COVID-19 on patients with diabetic nephropathy in comparison to patients with chronic kidney disease. METHODS: We used the Mexican Open Registry of COVID-19 patients 11 to analyze anonymized records of those who had symptoms related to COVID-19 to analyze the rates of SARS-CoV-2 infection, development of COVID-19 pneumonia, admission, intubation, Intensive Care Unit admission and mortality. Robust Poisson regression was used to relate sex and age to each of the six outcomes and find adjusted prevalences and adjusted prevalence ratios. Also, binomial regression models were performed for those outcomes that had significant results to generate probability plots to perform a fine analysis of the results obtained along age as a continuous variable. RESULTS: The adjusted prevalence analysis revealed that that there was a a 87.9% excess probability of developing COVID-19 pneumonia in patients with diabetic nephropathy, a 5% excess probability of being admitted, a 101.7% excess probability of intubation and a 20.8% excess probability of a fatal outcome due to COVID-19 pneumonia in comparison to CKD patients (p<0.01).  Conclusions: Patients with diabetic nephropathy had nearly a twofold rate of COVID-19 pneumonia, a higher probability of admission, a twofold probability of intubation and a higher chance of death once admitted compared to patients with chronic kidney disease alone. Also, both diseases had higher COVID-19 pneumonia rates, intubation rates and case-fatality rates compared to the overall population.


Subject(s)
COVID-19/complications , Diabetic Nephropathies/complications , Renal Insufficiency, Chronic/complications , Adult , Aged , COVID-19/epidemiology , COVID-19/therapy , Female , Hospitalization/statistics & numerical data , Humans , Intensive Care Units , Intubation, Intratracheal , Male , Mexico/epidemiology , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL